Abstract AB062. COX-2 inhibitors, a potential synergistic effect with antineoplastic drugs in lung cancer Kalliopi Domvri, Nikolaos Zogas, Paul Zarogoulidis, Konstantinos Porpodis, Savvas Petanidis, Efi Kioseoglou, Konstantinos Zarogoulidis
